Clinical Study
The Mode of Pretransplant Dialysis Does Not Affect Postrenal Transplant Outcomes in African Americans
Table 2
Dialysis modality and renal transplant outcomes.
| | Hemodialysis | Peritoneal dialysis | value |
| Patient survival (%) | | | | 1 year | 96.8 ± 1.0 | 95.2 ± 2.7 | ns | 3 years | 91.4 ± 1.5 | 90.3 ± 3.8 | ns | 5 years | 84.1 ± 2.0 | 87.0 ± 4.3 | ns | Graft survival (%) | | | | 1 year | 92.6 ± 1.4 | 90.6 ± 3.8 | ns | 3 years | 80.2 ± 2.2 | 75.8 ± 5.4 | ns | 5 years | 67.1 ± 2.6 | 72.6 ± 5.7 | ns | Outcomes (1st year) | | | | DGF | 130 (38.8%) | 11 (17.7%) | P < 0.005 | Vascular thrombosis | 2 | 0 | | Systemic infections | 99 (29.2%) | 15 (24.2%) | P = 0.45 | Wound infections | 20 (5.9%) | 2 (3.2%) | P = 0.36 | Rejection | 49 (14.5%) | 4 (6.5%) | P = 0.10 | Length of stay (d) | 6.6 ± 3.3 | 6.6 ± 2.5 | P = 0.99 |
|
|
Patient and graft survivals are given as percentage ± standard error, DGF: delayed graft function, ns: not significant (P > 0.05).
|